Anemia in elderly market projected to reach $4.59B by 2030

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Estimated Market Size Of The Anemia In Elderly Market In 2026, And How Will Its Value Evolve By 2030?

The anemia in elderly market has experienced substantial growth in recent years. This market is projected to expand from $2.99 billion in 2025 to $3.26 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.0%. Historically, this growth has been influenced by factors including aging population growth, increased prevalence of chronic diseases, availability of oral iron supplements, expansion of hospital-based anemia management, and rising awareness of nutritional deficiencies.

The anemia in elderly market size is projected to undergo substantial growth in the upcoming years, with expectations to reach $4.59 billion by 2030, advancing at a compound annual growth rate (CAGR) of 8.9%. This expansion during the forecast period can be attributed to the increasing demand for personalized anemia treatment, the rising adoption of long-acting injectables, a greater focus on geriatric healthcare, the widening scope of outpatient anemia management, and improved diagnostic screening within elderly care. Significant trends anticipated during this period include an increasing embrace of combination therapy approaches, a growing use of injectable iron treatments, an enhanced emphasis on early diagnosis in elderly populations, the expansion of home-based treatment options, and a heightened focus on managing chronic disease-related anemia.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/anemia-in-elderly-global-market-report

Which Strong Drivers Are Impacting The Anemia In Elderly Market Growth?

The increasing elderly population is anticipated to drive the future growth of the anemia in the elderly market. This demographic refers to the rising number and proportion of individuals aged 65 and above, either within a specific society or globally. Factors contributing to the expansion of this population include increased life expectancy, declining birth rates, and the aging of large generational cohorts. An expanding older demographic heightens the prevalence of age-related and chronic conditions, which are significant contributors to anemia in older adults. This, in turn, boosts the demand for the diagnosis, management, and treatment of anemia, thereby stimulating market development. For instance, in January 2024, the Population Reference Bureau, a Kenya-based Nonprofit organization, indicated that the population of Americans aged 65 and older is expected to increase from 58 million in 2022 to 82 million by 2050, marking a 47% growth. The proportion of this age group within the overall population is also projected to rise from 17% to 23% during the same period. Consequently, the expanding elderly population is a primary driver for the growth of the anemia in the elderly market.

How Is Segmentation Applied In The Anemia In Elderly Market Segment Analysis?

The anemia in elderly market covered in this report is segmented –

1) By Product Type: Tablets, Injectable

2) By Treatment: Iron Supplements, Erythropoietin Or Erythrocyte-Stimulating Agents, Vitamin B12 Supplements, Folic Acid Supplements

3) By Route Of Administration: Oral, Parenteral

4) By End User: Hospital pharmacy, Online Pharmacy, Retail pharmacy

Subsegments:

1) By Tablets: Iron Supplements, Vitamin B12 Supplements, Folic Acid Tablets, Erythropoiesis-Stimulating Agents (ESAs) Tablets

2) By Injectable: Iron Injections, Vitamin B12 Injections, Erythropoiesis-Stimulating Agents (ESAs) Injections, Folic Acid Injections

Which Trends Are Contributing To Changes In The Anemia In Elderly Market?

Major companies in the anemia in the elderly market are concentrating on technological breakthroughs, such as personalized therapies, to optimize treatment workflows, enhance patient results, decrease adverse effects, and improve overall healthcare efficiency. Customized therapies are medical interventions crafted based on each patient’s unique attributes. For example, in March 2024, Cadila Pharmaceuticals, an Indian pharmaceutical company, announced the introduction of Redshot FCM, a new iron injection developed to treat iron deficiency anemia for patients intolerant to oral iron. This intravenous iron preparation supplies ample iron and possesses an exemplary safety record. The injection utilizes an advanced Ferric Carboxymaltose formulation that improves iron delivery and absorption. Redshot FCM illustrates a commitment to enhancing healthcare through the development of personalized therapies that consider individual patient profiles, resulting in better treatment outcomes for iron deficiency anemia.

Who Are The Companies Participating In The Anemia In Elderly Market Environment?

Major companies operating in the anemia in elderly market are Johnson & Johnson, Roche Holding AG, Merck & Co Inc, Bristol-Myers Squibb Company, AstraZeneca plc, Novartis International AG, Takeda Pharmaceutical Company Limited, Amgen Inc, Japan Tobacco Inc, Fresenius Medical Care AG, Teva Pharmaceutical Industries Ltd, Sandoz International GmbH, CSL Limted, Daiichi Sankyo Company Limited, Amag Pharmaceuticals, Akebia Therapeutics Inc, Pharmacosmos A/S, Rockwell Medical Inc, Bioage Labs Inc, Shield Therapeutics Plc, MegaPro Biomedical Co Ltd

Get The Full Anemia In Elderly Market Report:

https://www.thebusinessresearchcompany.com/report/anemia-in-elderly-global-market-report

Which Region Dominates The Anemia In Elderly Market By Market Share?

North America was the largest region in the anemia in elderly market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anemia in elderly market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Anemia In Elderly Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/anemia-in-elderly-global-market-report

Browse Through More Reports Similar to the Global Anemia In Elderly Market 2026, By The Business Research Company

Anosmia Market Report 2026

https://www.thebusinessresearchcompany.com/report/anosmia-global-market-report

Chemotherapy Induced Anemia Market Report 2026

https://www.thebusinessresearchcompany.com/report/chemotherapy-induced-anemia-global-market-report

Aplastic Anemia Market Report 2026

https://www.thebusinessresearchcompany.com/report/aplastic-anemia-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795